4//SEC Filing
Schulz Marcus 4
Accession 0001437749-23-001484
CIK 0000834365other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:23 PM ET
Size
6.7 KB
Accession
0001437749-23-001484
Insider Transaction Report
Form 4
Schulz Marcus
Vice President, Global Sales
Transactions
- Sale
Common Stock
2023-01-18$25.04/sh−3,000$75,120→ 44,975 total - Sale
Common Stock
2023-01-19$22.93/sh−538$12,336→ 44,437 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001812702
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 7:23 PM ET
- Size
- 6.7 KB